Photobiomodulation Dosimetry s in Patients With Orofacial Pain

Launched by UNIVERSITY OF NOVE DE JULHO · Sep 29, 2023

Keywords

ClinConnect Summary

This clinical trial is looking at a new treatment called photobiomodulation, which uses light to help relieve orofacial pain and tension-type headaches. The researchers want to see how well this treatment works and how to use it most effectively. They will include 240 participants from different age groups, between 7 and 65 years old, and will measure various factors like skin type, weight, and heart rate, as well as gather information about pain levels through questionnaires. The goal is to develop better pain management options, especially for people who don’t respond well to medications.

To be eligible for the study, you must be between 7 and 65 years old and not have certain conditions, such as being pregnant, having heart rhythm issues, or using a pacemaker. Participants will receive either local or systemic laser therapy and will have their progress monitored through different measurements before, during, and after the treatment. The study is not yet recruiting participants, but it aims to provide valuable insights into managing pain without using traditional medications, which can sometimes cause unwanted side effects.

Gender

ALL

Eligibility criteria

• • Inclusion Criteria Individuals of both sexes, between 7 and 65 years of age Exclusion Criteria
• Participants with the following characteristics will be excluded:
• • Pregnant individuals Individuals with arrhythmia Individuals with Thrombocytopenia Individuals with Sickle Cell Anemia Individuals with a pacemaker Individuals with alterations in coagulation factors